Link to this page

Your search term(s) "hypoglycemia" returned 234 results.

Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24    Display All

Acute Hyperglycemia Alters Mood State and Impairs Cognitive Performance in People with Type 2 Diabetes. Diabetes Care. 27(10): 2335-2340. October 2004.

This article reports on a study of the effects of acute hyperglycemia on a range of important cognitive function and key mood states in a group of people with type 2 diabetes. The study included 20 subjects with type 2 diabetes, median age of 61.5 years, known duration of diabetes 5.9 years, body mass index (BMI) 29.8, and HbA1c (glycosylated hemoglobin, a measure of blood glucose over time) of 7.5 percent. Treatment modalities ranged from antidiabetes medications to insulin. Tests of information processing, immediate and delayed memory, working memory, and attention were administered, along with a mood questionnaire, during each experimental condition. The results showed that speed of information processing, working memory, and some aspects of attention were impaired during acute hyperglycemia. Subjects were significantly more dysphoric during hyperglycemia, with reduced energetic arousal and increased sadness and anxiety. The authors conclude that these findings are of practical importance because intermittent or chronic hyperglycemia is common in people with type 2 diabetes and may interfere with many daily activities through adverse effects on cognitive function and mood. 1 figure. 3 tables. 31 references.

Full Record   Printer Friendly Version

All About Blood Glucose for People with Type 2 Diabetes. Alexandria, VA: American Diabetes Association. 2004. 2 p.

Cardiovascular disease (CVD) is the leading cause of death among people with diabetes, accounting for at least two out of three diabetes-related deaths. This fact sheet on blood glucose in type 2 diabetes is from a set of 26 reproducible patient education handouts on topics related to diabetes CVD. In people with type 2 diabetes, the pancreas does not make enough insulin or the insulin does not work properly, or both. However, keeping blood glucose, blood pressure, and cholesterol on target can help prevent or delay problems. The fact sheet emphasizes that the closer the blood glucose stays to the targets, the more patients can lower their risk of blindness or diabetic retinopathy (eye disease), diabetic nephropathy (kidney disease), foot problems, nerve damage (diabetic neuropathy), tooth and gum disease (periodontal disease), and skin problems; patients may also lower their risks for heart attack and stroke. Topics include the causes of blood glucose levels rising and falling, blood glucose level targets for people with diabetes, how to keep track of blood glucose levels, the use of a blood glucose meter, problems with hyperglycemia (high levels of blood glucose), and problems with hypoglycemia (low levels of blood glucose). The fact sheet includes blank space for readers to record their goals and test results for blood glucose. 1 figure. 2 tables.

Full Record   Printer Friendly Version

Blood Glucose Log. Alexandria, VA: American Diabetes Association. 2004. 2 p.

Cardiovascular disease (CVD) is the leading cause of death among people with diabetes, accounting for at least two out of three diabetes-related deaths. This fact sheet is from a set of 26 reproducible patient education handouts on topics related to diabetes CVD. The fact sheet offers a brief summary of strategies for coping with low blood glucose levels (hypoglycemia); the bulk of the fact sheet then reproduces blank forms for readers to keep track of their medications and blood glucose levels. Each form includes space to record the date, the time, blood glucose level, and comments for breakfast, lunch, dinner, and snack times. There is also space to record the contact information for one's health care providers, as well as blood glucose targets. The fact sheet offers enough forms to track three weeks (readers are encouraged to photocopy enough forms for each month). Readers are also encouraged to contact the American Diabetes Association (800-342-2383 or www.diabetes.org) for more information.

Full Record   Printer Friendly Version

Diabetes Management in Correctional Institutions. Diabetes Care. 27(Supplement 1): S114-S120. January 2004.

This article provides a general set of guidelines for diabetes care in correctional institutions (a position statement of the American Diabetes Association). It is not designed to be a diabetes management manual. Rather, the discussion focuses on those areas where the care of people with diabetes in correctional facilities may differ from care of people with diabetes who are not in correctional facilities. Topics covered include intake medical assessment, including reception screening, intake screening, and intake physical examination and laboratory; screening for diabetes; patient care management plans; nutrition and food services; urgent and emergency issues, including hyperglycemia and hypoglycemia; medications; routine screening for and management of diabetes complications; monitoring glycemia; self-management education; staff education; alcohol and drugs; transfer and discharge considerations; sharing of medical information and records; children and adolescents with diabetes; and pregnancy. Recommendations for care are provided in each category. The authors conclude that patients must have access to medication and nutrition needed to manage their disease. In patients who do not meet treatment targets, medical and behavioral plans should be adjusted by health care professionals in collaboration with the prison staff. 1 figure. 2 tables. 15 references.

Full Record   Printer Friendly Version

Diabetes Self-Management Education. In: Hormel, A.P. and Mother, R. Davidson's Diabetes Mellitus: Diagnosis and Treatment. 5th ed. Orlando, FL: W.B. Saunders Company. 2004. p. 365-460.

Diabetes care is a complex balancing act in which individuals with the disease must assume much of their care; thus, they must be provided the opportunity to have the tools necessary to successfully manage their condition. Diabetes self-management education (DSME) must be an integral component of care for all patients to achieve successful diabetes and health-related outcomes. This chapter on DSME is from a textbook that provides readers with current information on the diagnosis and treatment of patients with diabetes, including the latest advances, medications, and research studies. In this chapter, the author reviews the goals of DSME; the possible impact of the educator's philosophy on self-management education; six components of the teaching and learning process; and ten key content areas for DSME. Topics include personal lifestyle, national standards for DSME, preteaching assessment, learning styles, behavior change strategies, curriculum development, nutrition management, exercise, monitoring blood glucose and ketone levels, medications (including insulin) for diabetes treatment, drug interactions, preventing and treating acute complications (hypoglycemia, hyperglycemia), sick day guidelines, foot care, autonomic neuropathy, peripheral neuropathy, hypoglycemia unawareness, oral health, and special populations. 19 figures. 11 tables. 4 references.

Full Record   Printer Friendly Version

Efficacy and Safety of Inhaled Insulin (Exubera) Compared With Subcutaneous Insulin Therapy in Patients With Type 2 Diabetes: Results of a 6-month, Randomized, Comparative Trial. Diabetes Care. 27(10): 2356-2362. October 2004.

This article reports on a study of the effectiveness and safety of inhaled insulin (Exhubera), compared with subcutaneous insulin therapy in patients with type 2 diabetes. The authors studied glycemic control in patients using inhaled, dry-powder insulin plus a single injection of long-acting insulin (n = 149), compared to that in patients (n = 150) using a conventional regimen (at least two daily insulin injections). The efficacy end point was the change in HbA1c (glycosylated hemoglobin, a measure of blood glucose levels over time) between baseline and 6 months later. The results showed that blood glucose levels decreased similarly in the inhaled and subcutaneous insulin groups. HbA1c levels less than 7 percent was achieved in more patients receiving inhaled (46.9 percent) than subcutaneous (31.7 percent) insulin. Overall hypoglycemia (events per subject-month) was slightly lower in the inhaled group, with no difference in severe events. Other adverse events, with the exception of increased cough in the inhaled insulin group, were similar. Treatment satisfaction was greater in the inhaled insulin group. The authors conclude that inhaled insulin appears to be effective, well-tolerated, and well accepted in patients with type 2 diabetes; inhaled insulin also provides glycemic control comparable to the conventional subcutaneous regimen. 1 figure. 2 tables. 28 references.

Full Record   Printer Friendly Version

Getting Started with Physical Activity. Alexandria, VA: American Diabetes Association. 2004. 2 p.

Cardiovascular disease (CVD) is the leading cause of death among people with diabetes, accounting for at least two out of three diabetes-related deaths. This fact sheet on getting started with physical activity for people with diabetes is from a set of 26 reproducible patient education handouts on topics related to diabetes CVD. The fact sheet first reviews the importance of physical activity for people with diabetes, then suggests ways to begin incorporating physical activity into one's regular habits. The fact sheet recommends a visit to the health care provider before starting a program of physical activity. The fact sheet defines a comprehensive physical activity routine as including four kinds of activities: being active throughout the day, aerobic exercise, strength training, and flexibility exercises (such as stretching). Additional sections discuss how activity affects blood glucose levels, the symptoms of low blood glucose (hypoglycemia), planning for exercise, and the importance of medical identification tags. A checklist of suggestions for getting started with physical activity is also provided. 2 figures.

Full Record   Printer Friendly Version

GlucoWatch G2TM Biographer Alarm Reliability During Hypoglycemia in Children. Diabetes Technology & Therapeutics. 6(5): 559-566. October 2004.

The GlucoWatch G2 Biographer (GW2B) (Cygnus, Inc., Redwood City, CA) is a new device that provides near-continuous monitoring of glucose values in near real time. This device is equipped with two types of alarms to detect hypoglycemia. The hypoglycemia alarm is triggered when the current glucose measurement falls below the level set by the user. The "down alert" alarm is triggered when extrapolation of the current glucose trend anticipates hypoglycemia to occur within the next 20 min. This article reports on a study undertaken to assess the performance of these alarms. During a 24-hour clinical research center stay, 89 children and adolescents with Type 1 diabetes mellitus (3.5 years to 17.7 years old) wore 174 GW2B devices and had frequent serum glucose determinations during the day and night. Results showed that sensitivity to detect hypoglycemia (reference glucose 60 mg per dL) during an insulin-induced hypoglycemia test was 24 percent with the hypoglycemia alarm alone and 88 percent when combined with the down alert alarm. Overnight sensitivity from 11 p.m. to 6 a.m. was 23 percent with the hypoglycemia alarm alone and 77 percent when combined with the down alert alarm. The authors conclude that the down alert alarm substantially improves the sensitivity of the GW2B to detect hypoglycemia at the price of a large increase in the false alarm rate (up to 62 percent). The utility of these alarms in the day-to-day management of children with diabetes remains to be determined. 2 figures. 3 tables. 16 references.

Full Record   Printer Friendly Version

Holiday Travel Tips. Diabetes Forecast. 57(12): 71-72. December 2004.

This article offers holiday travel tips for people with diabetes. The suggestions were developed by the Transportation Security Administration (TSA) with the assistance of the American Diabetes Association (ADA). The author provides suggestions for getting through the airline security gate (with medications, syringes, etc.), potential problems with an insulin pump (which will trip the metal detector), and handling a low blood glucose reaction (hypoglycemia) during the security procedure. The ideas provided are designed to encourage the safety and convenience of travelers with diabetes. Readers are referred to the TSA toll-free telephone number to report any experiences with unfair treatment (866-289-9673).

Full Record   Printer Friendly Version

Hyperglycemic and Hypoglycemic Emergencies. In: Hormel, A.P. and Mother, R. Davidson's Diabetes Mellitus: Diagnosis and Treatment. 5th ed. Orlando, FL: W.B. Saunders Company. 2004. p. 147-187.

Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are profound metabolic complications of diabetes and are among the most serious acute complications, along with severe hypoglycemia (low blood glucose levels). Both of the hyperglycemic (high blood glucose conditions) can occur in type 1 or type 2 diabetes, as can hypoglycemia. This chapter on hyperglycemic and hypoglycemic emergencies is from a textbook that provides readers with current information on the diagnosis and treatment of patients with diabetes, including the latest advances, medications, and research studies. This chapter addresses the pathophysiology, causes, signs, symptoms, and treatment of hyperglycemic emergencies, and outlines specific differences between DKA and HHS in these regards. The final section of this chapter focuses on hypoglycemia, its causes, manifestations, and management. 10 figures. 13 tables. 103 references.

Full Record   Printer Friendly Version

Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24    Display All

Start a new search.